Endoscopic Bipolar Radiofrequency Probe (ENDOHPB) in the Management of Unresectable Bile Duct and Pancreatic Cancer

NCT01303159 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

29

Enrollment

OTHER

Sponsor class

Stopped EndoHPB probe is FDA approved and considered standard of care

Conditions

Cholangiocarcinoma
Pancreatic Cancer

Interventions

DEVICE: Endoscopic bipolar radiofrequency probe (ENDOHPB)

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]